Search results
19 gru 2019 · Unlike conventional antidepressant medications, a single dose of a psychedelic substance such as psilocybin can have an immediate effect on depressive symptoms. Until recently, chemical abnormalities or “imbalances” in the brain were believed to be a major cause of depression.
19 gru 2019 · Recent studies evaluating psychedelic-assisted therapy (PAT) using various forms of psychedelics such as LSD, psilocybin, peyote, MDMA, ibogaine, and ketamine are all showing potential for various mental health conditions.
24 lut 2021 · Particularly in Canada, we can first look to August 2020, when four palliative care patients were granted access by Health Minister Patty Hajdu to receive psilocybin-assisted therapy to treat their ‘end-of-life’ distress.
We’ll share findings in research on psychedelics such as Psilocybin, LSD, Mescaline, and Ayahuasca as well as non-psychedelic hallucinogens like Ketamine and MDMA on disorders like anxiety, depression, addiction, PTSD, OCD and much more.
3 maj 2021 · In this first Phase 3 trial of any psychedelic-assisted therapy, participants who received MDMA-assisted therapy reported a significant reduction in PTSD symptoms compared to those who received placebo with therapy (p<0.0001), successfully achieving the prespecified primary endpoint for the trial.
11 kwi 2022 · Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new study by scientists at UC San Francisco and Imperial College London.
This episode introduces listeners to MAPS Canada, it’s mission, goal, and future vision for the safe and beneficial use of psychedelics to treat mental illnesses. This episode also provides an introductory overview of what psychedelics are and how they came to be.
